Qelbree generic cost?

How does the cost of Qelbree compare to other ADHD treatments?

Qelbree (viloxazine extended-release) is a medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) in adults. Generic versions of Qelbree are not yet available, as the patent for the medication has not yet expired.

What is the current cost of Qelbree?

The cost of Qelbree can vary depending on several factors, including your location, insurance coverage, and pharmacy. According to the manufacturer, Takeda Pharmaceuticals, the list price for a 28-tablet bottle of Qelbree (400 mg) can range from around $530 to over $1,000, depending on the strength and quantity [1].

When can I expect a generic version of Qelbree?

According to DrugPatentWatch.com [2], the patent for Qelbree is set to expire in 2027. However, this date is subject to change, and the availability of generic versions may be affected by various factors, including patent litigation and regulatory approvals.

What impact will the generic version have on the cost of Qelbree?

When a generic version of Qelbree becomes available, it is likely to significantly reduce the cost of the medication. Generic drugs are typically priced at 80-85% less than their brand-name counterparts, according to the FDA [3]. This could make Qelbree more accessible to patients who are currently priced out of the medication.

Sources:

[1] Takeda Pharmaceuticals. (n.d.). Qelbree. Retrieved from https://www.takedapharmaceuticals.com/us/en/products/qelbree.html

[2] DrugPatentWatch.com. (n.d.). Qelbree (viloxazine extended-release). Retrieved from https://www.drugpatentwatch.com/product/qelbree

[3] FDA. (n.d.). Generic Drugs: FDA FAQs. Retrieved from https://www.fda.gov/drugs/new-drugs-and-biologicals/approvations-and-safety-information/abbreviated-new-drug-applications-and-510k-clearances/generic-drugs-fda-faqs